Epigenetic targeting of Mcl-1 Is synthetically lethal with Bcl-xL/Bcl-2 inhibition in model systems of glioblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancers ; 12 (2020), 8. - Art.-Nr. 2137. - eISSN 2072-6694
- Schlagwort
-
Krebs
Glioblastom
Apoptosis
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2020
- Urheber
-
Shang, Enyuan
Nguyen, Trang T. T.
Shu, Chang
Westhoff, Mike-Andrew
Karpel-Massler, Georg
Siegelin, Markus D.
- DOI
-
10.18725/OPARU-44611
- URN
-
urn:nbn:de:bsz:289-oparu-44687-2
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shang, Enyuan
- Nguyen, Trang T. T.
- Shu, Chang
- Westhoff, Mike-Andrew
- Karpel-Massler, Georg
- Siegelin, Markus D.
- Universität Ulm
Entstanden
- 2020
Ähnliche Objekte (12)
Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems
The BCL-2 family in glioblastoma
Rolle von Bcl-2, Bcl-xl und Mcl-1 für die Apoptoseresistenz und Chemoresistenz des Pankreaskarzinoms
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
Selective Affimers Recognise the BCL‐2 Family Proteins BCL‐x L and MCL‐1 through Noncanonical Structural Motifs **
Photodynamic therapy combined with Bcl-2/Bcl-xL inhibition increases the Noxa/Mcl-1 ratio independent of usp9X and synergistically enhances apoptosis in glioblastoma
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
b-cl
b-cl
b-cl
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems
The BCL-2 family in glioblastoma
Rolle von Bcl-2, Bcl-xl und Mcl-1 für die Apoptoseresistenz und Chemoresistenz des Pankreaskarzinoms
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
Selective Affimers Recognise the BCL‐2 Family Proteins BCL‐x L and MCL‐1 through Noncanonical Structural Motifs **
Photodynamic therapy combined with Bcl-2/Bcl-xL inhibition increases the Noxa/Mcl-1 ratio independent of usp9X and synergistically enhances apoptosis in glioblastoma
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
b-cl
b-cl
b-cl
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems
The BCL-2 family in glioblastoma
Rolle von Bcl-2, Bcl-xl und Mcl-1 für die Apoptoseresistenz und Chemoresistenz des Pankreaskarzinoms
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
Selective Affimers Recognise the BCL‐2 Family Proteins BCL‐x L and MCL‐1 through Noncanonical Structural Motifs **
Photodynamic therapy combined with Bcl-2/Bcl-xL inhibition increases the Noxa/Mcl-1 ratio independent of usp9X and synergistically enhances apoptosis in glioblastoma
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
b-cl
b-cl
b-cl